You must log in to view this page.

Kalaris Therapeutics Inc. – Filings and Transcripts

NASDAQ: KLRS
Share price (6/2/26): $4.65
Market cap (6/2/26): $111 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Shelf registration

Shelf registration

Registration of securities for employees

Ownership Filter

Samsara BioCapital, L.P.

Akkaraju Srinivas, Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC

News Filter

Reports First Quarter 2026 Financial Results and Provides Business Updates

Change in Directors, Officers or Compensation

Reports Full Year 2025 Financial Results and Provides Business Updates

Investor Presentation

Announces Oversubscribed $50.0 Million Private Placement

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC